Assessing antiretroviral adherence via electronic drug monitoring and self-report: an examination of key methodological issues

AIDS Behav. 2007 Mar;11(2):161-73. doi: 10.1007/s10461-006-9133-3.

Abstract

We explored methodological issues related to antiretroviral adherence assessment, using 6 months of data collected in a completed intervention trial involving 136 low-income HIV-positive outpatients in the Bronx, NY. Findings suggest that operationalizing adherence as a continuous (versus dichotomous) variable and averaging adherence estimates over multiple assessment points (versus using only one) explains greater variance in HIV-1 RNA viral load (VL). Self-reported estimates provided during a phone interview accounted for similar variance in VL as EDM estimates (R (2) = .17 phone versus .18 EDM). Self-reported adherence was not associated with a standard social desirability measure, and no difference in the accuracy of self-report adherence was observed for assessment periods of 1-3 days. Self-reported poor adherence was more closely associated with EDM adherence estimates than self-reported moderate and high adherence. On average across assessment points, fewer than 4% of participants who reported taking a dose of an incorrect amount of medication.

Publication types

  • Evaluation Study
  • Research Support, N.I.H., Extramural
  • Research Support, Non-U.S. Gov't

MeSH terms

  • Adult
  • Aged
  • Anti-HIV Agents / therapeutic use*
  • Drug Monitoring / instrumentation
  • Drug Monitoring / methods*
  • Electronics / instrumentation
  • Female
  • HIV Infections / drug therapy*
  • HIV Infections / virology
  • HIV-1
  • Humans
  • Male
  • Middle Aged
  • Patient Compliance* / statistics & numerical data
  • RNA, Viral / blood
  • Self Disclosure
  • Viral Load

Substances

  • Anti-HIV Agents
  • RNA, Viral